We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test Detects Parasite Responsible for Trichomoniasis Infection In 15 Minutes

By LabMedica International staff writers
Posted on 27 Feb 2025

Trichomoniasis is one of the most prevalent sexually transmitted infections globally. More...

It is caused by the parasite Trichomonas vaginalis, which is often difficult to detect as the infection is frequently asymptomatic, making diagnosis and treatment challenging. Early detection is crucial, as untreated infections can lead to reproductive health issues, increase the likelihood of HIV transmission, and cause genital tract inflammation. In response to this challenge, researchers have developed a rapid, cost-effective, and easy-to-use test for detecting the parasite. The findings from this research were published in Sensors & Diagnostics.

The test, called ALFA (Aptamer-based Lateral Flow Assay), was developed by a team from Universitat Rovira i Virgili (Tarragona, Spain) using innovative DNA aptamer technology. Aptamers are short nucleic acid sequences that can bind highly specifically to target molecules. The test employs a dual aptamer system: one aptamer is immobilized on a nitrocellulose membrane as a capturer, and the other is linked to gold nanoparticles, which generate a visual detection signal. This design helps to reduce production costs and enhances the stability of the test. One of the key benefits of this test is its affordability, costing under one euro. This makes it a viable tool for use in public health initiatives and in countries with limited healthcare resources.

The researchers demonstrated that the test can detect very low concentrations of the parasite without being confused by other common vaginal microorganisms, ensuring its accuracy. Stability is another significant advantage, as the test components retain their effectiveness for up to a year at room temperature (22 ºC), eliminating the need for refrigeration or special packaging. This feature makes the test suitable for distribution in resource-limited areas. Furthermore, the test is straightforward to use, requiring only three simple steps from sample collection to result, which can be obtained in about 15 minutes. In initial trials using clinical samples, the results were consistent with those obtained through the traditional method of direct observation. The research team plans to continue expanding its approach to detect other pathogens in the future.

Related Links:
Universitat Rovira i Virgili


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.